Undifferentiated Connective Tissue Disease-Associated Interstitial Lung Disease: Changes in Lung Function

被引:42
|
作者
Kinder, Brent W. [1 ,2 ]
Shariat, Cyrus [3 ]
Collard, Harold R. [4 ]
Koth, Laura L. [4 ]
Wolters, Paul J. [4 ]
Golden, Jeffrey A. [4 ]
Panos, Ralph J. [1 ,2 ]
King, Talmadge E., Jr. [4 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Med, Div Pulm Crit Care & Sleep Med, Cincinnati, OH 45267 USA
[2] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA
[3] NYU, Dept Med, New York, NY 10016 USA
[4] Univ Calif San Francisco, San Francisco Sch Med, Dept Med, San Francisco, CA 94143 USA
关键词
Idiopathic interstitial pneumonia; Systemic rheumatic disease; Undifferentiated connective tissue; Collagen vascular disease; Autoimmune disease; IDIOPATHIC PULMONARY-FIBROSIS; PLACEBO-CONTROLLED TRIAL; PROGNOSTIC-SIGNIFICANCE; PNEUMONIA; CYCLOPHOSPHAMIDE; CLASSIFICATION; SURVIVAL; CTD;
D O I
10.1007/s00408-009-9226-7
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Undifferentiated connective tissue disease (UCTD) is a distinct clinical entity that may be accompanied by interstitial lung disease (ILD). The natural history of UCTD-ILD is unknown. We hypothesized that patients with UCTD-ILD would be more likely to have improvement in lung function than those with idiopathic pulmonary fibrosis (IPF) during longitudinal follow-up. We identified subjects enrolled in the UCSF ILD cohort study with a diagnosis of IPF or UCTD. The primary outcome compared the presence or absence of a a parts per thousand yen5% increase in percent predicted forced vital capacity (FVC) in IPF and UCTD. Regression models were used to account for potential confounding variables. Ninety subjects were identified; 59 subjects (30 IPF, 29 UCTD) had longitudinal pulmonary function data for inclusion in the analysis. After accounting for baseline pulmonary function tests, treatment, and duration between studies, UCTD was associated with substantial improvement in FVC (odds ratio = 8.23, 95% confidence interval, 1.27-53.2; p = 0.03) during follow-up (median, 8 months) compared with IPF. Patients with UCTD-ILD are more likely to have improved pulmonary function during follow-up than those with IPF. These findings demonstrate the clinical importance of identifying UCTD in patients presenting with an "idiopathic" interstitial pneumonia.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 50 条
  • [1] Undifferentiated Connective Tissue Disease-Associated Interstitial Lung Disease: Changes in Lung Function
    Brent W. Kinder
    Cyrus Shariat
    Harold R. Collard
    Laura L. Koth
    Paul J. Wolters
    Jeffrey A. Golden
    Ralph J. Panos
    Talmadge E. King
    [J]. Lung, 2010, 188 : 143 - 149
  • [2] Connective tissue disease-associated interstitial lung disease
    Storrer, Karin Mueller
    Mueller, Carolina de Souza
    de Albuquerque Pessoa, Maxwell Cassio
    de Castro Pereira, Carlos Alberto
    [J]. JORNAL BRASILEIRO DE PNEUMOLOGIA, 2024, 50 (01)
  • [3] Connective tissue disease-associated interstitial lung disease
    Oliveira, R. P.
    Ribeiro, R.
    Melo, L.
    Grima, B.
    Oliveira, S.
    Alves, J. D.
    [J]. PULMONOLOGY, 2022, 28 (02): : 113 - 118
  • [4] Connective Tissue Disease-Associated Interstitial Lung Disease
    Fischer, Aryeh
    Brasington, Richard D.
    [J]. CURRENT RESPIRATORY MEDICINE REVIEWS, 2015, 11 (02) : 72 - 72
  • [5] Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease
    Fischer, Aryeh
    Brown, Kevin K.
    Du Bois, Roland M.
    Frankel, Stephen K.
    Cosgrove, Gregory P.
    Fernandez-Perez, Evans R.
    Huie, Tristan J.
    Krishnamoorthy, Mahalakshmi
    Meehan, Richard T.
    Olson, Amy L.
    Solomon, Joshua J.
    Swigris, Jeffrey J.
    [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (05) : 640 - 646
  • [6] Imaging in connective tissue disease-associated interstitial lung disease
    Rao, Praveen R. G.
    Joshi, Kushal
    Liyanage, Sidath
    Dalili, Daniel
    Koduri, Gouri
    [J]. INDIAN JOURNAL OF RHEUMATOLOGY, 2021, 16 (05) : 58 - 68
  • [7] Rituximab for connective tissue disease-associated interstitial lung disease
    Manfredi, Andreina
    Salvarani, Carlo
    Sebastiani, Marco
    [J]. LANCET RESPIRATORY MEDICINE, 2023, 11 (01): : 3 - 4
  • [8] Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease
    Bonella, Francesco
    Costabel, Ulrich
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 35 (02) : 181 - 200
  • [9] Pneumothorax in connective tissue disease-associated interstitial lung disease
    Nishimoto, Koji
    Fujisawa, Tomoyuki
    Yoshimura, Katsuhiro
    Enomoto, Yasunori
    Yasui, Hideki
    Hozumi, Hironao
    Karayama, Masato
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Inui, Naoki
    Sumikawa, Hiromitsu
    Johkoh, Takeshi
    Suda, Takafumi
    [J]. PLOS ONE, 2020, 15 (07):
  • [10] Management of Connective Tissue Disease-Associated Interstitial Lung Disease
    Kawano-Dourado, Leticia
    Lee, Joyce S.
    [J]. CLINICS IN CHEST MEDICINE, 2021, 42 (02) : 295 - 310